Maculopapular rash
Showing 1 - 25 of 436
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
Clinical Characteristics and Long-term Outcomes of Brucellosis
Completed
- Brucellosis
-
Huanggang, Hu Bei Province, China
- +7 more
Aug 17, 2023
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis Trial in Worldwide (AZD4831, Placebo)
Recruiting
- Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
- AZD4831
- Placebo
-
Chandler, Arizona
- +45 more
Jan 11, 2023
Colorectal Cancer Metastatic Trial in United States (durvalumab, Tremelimumab)
Completed
- Colorectal Cancer Metastatic
-
Duarte, California
- +17 more
Nov 8, 2022
Chikungunya Virus Infection Trial in United States (VLA1553, Placebo)
Completed
- Chikungunya Virus Infection
- VLA1553
- Placebo
-
Chandler, Arizona
- +43 more
Jul 25, 2022
Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi
Completed
- Cutaneous Manifestations
- +7 more
-
Karachi, Sindh, PakistanJinnah Postgraduate Medical Centre
Nov 12, 2021
Opioid Use Disorder Trial in Richmond (SUBLOCADE)
Terminated
- Opioid Use Disorder
-
Richmond, VirginiaVirginia Commonwealth University
Apr 8, 2022
HIV, COPD (COPD), Emphysema Trial in New York (Doxycycline, Placebo (sugar pill))
Completed
- HIV
- +2 more
- Doxycycline
- Placebo (sugar pill)
-
New York, New YorkGenetic Medicine
Jul 13, 2022
Penicillin Allergy Trial (Amoxicillin 250 MG)
Not yet recruiting
- Penicillin Allergy
- Amoxicillin 250 MG
- (no location specified)
Feb 11, 2022
Graft-versus-host-disease, GVHD Trial in United States (Alpha 1-Antitrypsin)
Completed
- Graft-versus-host-disease
- GVHD
- Alpha 1-Antitrypsin
-
Duarte, California
- +4 more
Jun 17, 2021
Breast Cancer Trial in United States (Benralizumab, fulvestrant or AIs) and PI3K inhibition (alpelisib))
Recruiting
- Breast Cancer
- Benralizumab
- fulvestrant or AIs) and PI3K inhibition (alpelisib)
-
Stanford, California
- +8 more
Aug 1, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022
Melanoma Trial in New York (Nivolumab, Ipilimumab)
Completed
- Melanoma
- Nivolumab
- Ipilimumab
-
New York, New YorkLaura and Isaac Perlmutter Cancer Center
Aug 11, 2022
Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7
Completed
- Stage III Intrahepatic Cholangiocarcinoma AJCC v7
- +8 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2022
Diaper Rash, Preterm Neonates Trial in Mersa Matruh (Colloidal oatmeal, Cold cream)
Active, not recruiting
- Diaper Rash
- Preterm Neonates
- Colloidal oatmeal
- Cold cream
-
Mersa Matruh, EgyptMatrouh university
May 26, 2023
Head Neck Cancer Trial in Boston (Nivolumab, Ipilimumab, Standard of Care Surgery)
Active, not recruiting
- Head and Neck Cancer
- Nivolumab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 22, 2022
MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))
Completed
- MGMT-unmethylated Glioblastoma (GBM)
- GBM
- Nivolumab
- +2 more
-
New York, New YorkNew York University School of Medicine
Jun 30, 2022
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Evaluation and Follow-up of People With Tick-borne Diseases
Recruiting
- Lyme Disease
- Tick-Borne Disease
-
Baltimore, MarylandUniversity of Maryland Baltimore, Department of Medicine
Feb 2, 2023
Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)
Terminated
- Hepatocellular Carcinoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 17, 2022
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Sporadic Angiomyolipomas (AMLs) Trial in United States (Everolimus)
Terminated
- Sporadic Angiomyolipomas (AMLs)
-
New Haven, Connecticut
- +7 more
Feb 16, 2021
Diaper Rash, Olive Oil Trial in Karaman (Olive oil)
Completed
- Diaper Rash
- Olive Oil
- Olive oil
-
Karaman, Central, TurkeyKaramanoglu Mehmetbey University
Apr 6, 2022